[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
news su OGM
U.S. WEIGHS WTO CASE AGAINST EU'S GENETICALLY MODIFIED FOOD
BAN
November 19, 2001
Bloomberg.com
Adrian Cox, and James G. Neuger,
Brussels -- The U.S. may file a World Trade Organization
complaint to force
the European Union to end a three-year ban on genetically
modified foods, a
U.S. trade official said.
France last month led a five-country coalition that blocked
efforts to
overturn the EU ban, which curbs European sales of companies
such as Aventis
CropScience, Syngenta AG and Monsanto Co.
``There's a recognition that you've got a problem if your
products aren't
getting onto the market,'' said
Grant Aldonas, the U.S. Commerce Department's undersecretary
for
international trade. ``At some point'' the U.S. will say
``that's a WTO
trading violation.''
The European Commission, the EU's regulatory arm, is trying to
jump-start EU
approval of GM products by passing tighter regulations to label
and trace
them through the food chain. A commission study rebutted claims
by some
environmental groups that the products are a health hazard.
EU scientists have already approved 12 GM products for use in
the bloc,
though opposition from member states means they've yet to be
marketed. The
U.S. and Canada have approved about 50 gene- modified crop
varieties,
compared with 13 in the EU. GM products tested by the EU
declined from 256
in 1997 to 44 this year.
The U.S. produces 70 percent of the world's 40 million hectares
(99 million
acres) of GM crops, while
Argentina produces 14 percent, Canada 9 percent and the EU just
0.03
percent, according to the commission.
AUSTRALIAN INSURERS WARY OF GM CROPS
November 18, 2001
Farmers Weekly Interactive
Boyd Champness
http://www.fwi.co.uk/live/ozworld.html
AUSTRALIA'S green movement received an unlikely boost in its
fight against
genetically modified crops last week when the insurance
industry admitted it
was reluctant to cover the biotechnology industry against
litigation.
The Insurance Council of Australia (ICA) has said that it is
loath to insure
farmers, biotechnology and food companies for claims involving
GM foods.
It would mean farmers growing GM crops at their own risk,
leaving them
personally liable for any future damages claims.
The Weekly Times newspaper reported that the insurance industry
feared a
repeat of the situation similar to the Wittenoom asbestos
disaster, in which
mining companies were sued for millions of dollars in damages
by workers who
contracted cancer years after being exposed to the deadly
mineral.
The insurance council believes "the unforeseen risks of
genetically modified
foods may be too high for insurers".
The newspaper said insurers were wary of lawsuits involving
consumers
claiming allergic reactions to GM foods, contamination of
non-GM crops and
the development of mutant herbicide-resistant weeds.
The insurance council said, because the technology is new and
complex, there
is no way of assessing the risk of damages claims arising in
the future and
therefore no way of setting insurance premiums.
"It is such a new technology, it is virtually impossible to
assess the risks
down the track,"
ICA spokesman Rod Frail said.
And defending GM claims in court could prove difficult because
of the
complexity of the technology, the ICA said.
Two of Australia's biggest farm insurers, CGU and Elders,
confirmed their
uneasiness with GM crops to the Weekly Times.
"GM technology is still in its infancy and research on any
direct or
indirect impacts is far
from conclusive," CGU spokesman Chris Jackson told the paper.
Mr Jackson said farmers who intend to grow a GM crop should
declare it and
cover would be "assessed on its merits".
Elders national insurance manager Kim Perrin said farmers
should not assume
they were
automatically covered under their normal public liability
policies, and
should check with
insurers before proceeding with GM crops.
Product liability lawyer David Poulton, from Minter Ellison,
told the Weekly
Times that
insurance companies were likely to insert exclusion clauses in
policies or
decline to cover the risks associated with biotechnology
altogether.
Alessandro Gimona
agimona@libero.it